Navigation Links
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
Date:6/3/2008

tacarpophalangeal (MP) or proximal interphalangeal (PIP) joints to < / = 5 degrees of normal. In CORD I, MP and PIP patients were stratified in a 2:1 ratio.

All patients receiving XIAFLEX in the double-blind portion of the study will be monitored for a minimum of 12 months following initial dosing. After finishing the double-blind portion, XIAFLEX and placebo patients are also eligible to receive additional XIAFLEX injections for either unsuccessfully treated joints or additional untreated joints during an open-label, extended treatment period. This open-label phase was designed to provide further data for the long-term safety and efficacy of XIAFLEX injections in the treatment of Dupuytren's contracture.

About CORD II

This Australian study is a supportive double-blind, randomized, placebo-controlled study with an open-label extension that enrolled 66 patients in five sites. The design of this study is similar to that of the pivotal U.S. phase III trial (CORD I) and its open-label extension. The primary endpoint was the reduction of contracture angle in MP or PIP joints to < / = 5 degrees of normal. In CORD II, MP and PIP patients were stratified in a 1:1 ratio.

After finishing this double-blind portion, patients from both XIAFLEX and placebo groups will be permitted to receive additional XIAFLEX injections for either unsuccessfully treated joints or additional untreated joints during an open-label, extended treatment period. This open-label phase was designed to provide further data for the long-term safety and efficacy of XIAFLEX injections in the treatment of Dupuytren's contracture.

About JOINT I and II

In addition to the open-label extensions of CORD I and II, the Company is concurrently conducting two phase III open-label studies in approximately 600 patients. These studies will provide additional safety and efficacy data and will contribute to the safety database that is required for the BLA.

About Auxilium '/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
3. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
4. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
5. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
6. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
7. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
8. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
9. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
10. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
11. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... MECHELEN, Belgium , May 17, 2013 ... ABBV ) announced today an extension of ... Galapagos will fund and complete a Phase 2 program ... progression into Phase 3.  Upon successful completion of the ... $50 million.  The terms of the collaboration extension are ...
(Date:5/16/2013)... Therapeutics, (Nasdaq: NKTR ) President and Chief Executive ... to present at the upcoming 2013 UBS Global Healthcare Conference ... New York Hotel on Tuesday, May 21, 2013 at 10:00 ... via a Webcast through a link posted in the Investor ... . This Webcast will be available for replay until June ...
(Date:5/16/2013)... , May 16, 2013  HeartWare International, Inc. (NASDAQ: ... of less invasive, miniaturized circulatory support technologies that are revolutionizing ... Doug Godshall is scheduled to present ... EDT on Monday, May 20, 2013.  The conference is being ... A live webcast of the Company,s presentation at ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
(Date:5/19/2013)... (PRWEB) May 19, 2013 In partnership with ... E-dentist.com has announced the launch of an SEO website for ... get high rankings in Google. , http://www.e-dentists.com/ , ... pay for the service until they see results. Dentists can ... lead generation websites run by JD Media Surge, LLC rank ...
(Date:5/19/2013)... Today, Zane Benefits, Inc. published ... insurance . Zane Benefits, which provides comprehensive and ... is the leader in health care reform, ... . , According to Zane Benefits’ website, many ... the value of small business health insurance for ...
(Date:5/19/2013)... May 19, 2013 6Webs.com is the ... companies. Homeowners who are considering an alarm system can ... the nation's leading security system providers online at 6Webs.com. ... best DIY home security system companies, 6Webs.com ... reviews dozens of home security companies before ranking the ...
(Date:5/19/2013)... Seattle, Wa (PRWEB) May 19, 2013 ... new fat loss program that provides people with ... instructions. When people order this Fat Burning Furnace package, ... other materials that they can download quickly. The Fat ... information that helps people build lean muscle mass. In ...
(Date:5/19/2013)... Farming methods have changed many times since man ... ago. Most recently, the Green Revolution has transformed farming ... seeds and by applying chemical fertilizers and pesticides. But ... due to the adverse environmental and health effects of ... interest in organic, sustainable farming practices and techniques. Enter ...
Breaking Medicine News(10 mins):Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3
... NEW YORK, March 12 On the second annual ... are working together to help educate patients diagnosed with ... the condition. Glaucoma is a worldwide epidemiological challenge affecting ... estimated 50 percent of glaucoma cases remaining undiagnosed. ...
... exposure to cold and flu virusesCLEVELAND, March 12 ... Postgraduate Medicine suggests that a strain of ... GBI-30, PTA-6086), increases the body,s immune response to viruses ... colds and flu. Study data showed significant increases ...
... to have aggressive brain surgery after suffering a severe ... to live longer, according to research by neurologists at ... should help patients and families put into perspective a ... make whether putting a patient through aggressive surgery ...
... to mathematics to build a computerized 3D model ... and other clothes designers make more sensuous, comfortable, ... Kensuke Nakamura of Kyoto Institute of Technology and ... components is critical for designing close-fitting products, whether ...
... Provides Safe, Secure and Effective Ways for Physicians ... to More Than 1,000 Healthcare Connections Across AmericaCARROLLTON, ... recently announced the 1,000th connection of Prime Exchange ... that allows data to be electronically shared between ...
... MIAMI, March 12 March 12 has been proclaimed ... globe. According to the World Health Organization, more ... suffer horribly from total incurable Glaucoma-Blindness. Most lacked the ... slowly robbed them of all their sight. Dr. Robert ...
Cached Medicine News:Health News:VIDEO from Medialink and Pfizer Ophthalmics: On World Glaucoma Day, Keep an Eye on the Future 2Health News:New Study Shows Probiotic Strain Effective in Boosting Immune Response 2Health News:New Study Shows Probiotic Strain Effective in Boosting Immune Response 3Health News:New Study Shows Probiotic Strain Effective in Boosting Immune Response 4Health News:Weighing the options after life-altering stroke 2Health News:Weighing the options after life-altering stroke 3Health News:Weighing the options after life-altering stroke 4Health News:Studying the female form 2Health News:Greenway Medical Technologies' Interoperability Engine, PrimeExchange, Allows Physicians to Securely Share Patient Data Amongst Wide Range of Providers in Patient's Care Continuum 2Health News:Greenway Medical Technologies' Interoperability Engine, PrimeExchange, Allows Physicians to Securely Share Patient Data Amongst Wide Range of Providers in Patient's Care Continuum 3Health News:Greenway Medical Technologies' Interoperability Engine, PrimeExchange, Allows Physicians to Securely Share Patient Data Amongst Wide Range of Providers in Patient's Care Continuum 4Health News:Greenway Medical Technologies' Interoperability Engine, PrimeExchange, Allows Physicians to Securely Share Patient Data Amongst Wide Range of Providers in Patient's Care Continuum 5Health News:Welsh 'Self-Test' to Help Cure Glaucoma on World Glaucoma Day 2
... are ideal for PCR and ... any work where aerosol contamination ... for pipetting DNA/RNA solutions, infectious ... For applications requiring absolute sterility, ...
Inquire...
... Filters are ideal for PCR ... for any work where aerosol ... designed for pipetting DNA/RNA solutions, ... other. For applications requiring absolute ...
... Aerosol barrier tips eliminate false signals ... designed and tested, Promega Barrier Tips ... with amplified nucleic acids (PCR(a)), radioactive ... forensic and serological specimens. , ,Promega ...
Medicine Products: